Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2018 pubmed 74 citations

Peptide LL-37 coating on micro-structured titanium implants to facilitate bone formation in vivo via mesenchymal stem cell recruitment.

He. Ye Y; Mu. Caiyun C; Shen. Xinkun X; Yuan. Zhang Z; Liu. Ju J; Chen. Weizhen W; Lin. Chuanchuan C; Tao. Bailong B; Liu. Bin B; Cai. Kaiyong K

Key Findings

  • LL-37 coating on micro‑structured titanium improves stem cell (MSC) adhesion, migration, and bone‑forming (osteogenic) activity in vitro.
  • In rats with a femur defect, implants with the LL-37 coating attracted more MSCs and showed significantly more new bone formation after 4 weeks.
  • The coating was applied using a polydopamine layer, which helped attach LL-37 securely to the titanium surface.

Practical Outcomes

  • For most biohackers this research isn’t directly usable because it involves implant surgery and a specialized coating process. However, it hints that LL-37 could one day be part of therapies to speed bone healing or improve implant integration, though more work is needed before it becomes a DIY or clinical option.

Summary

Scientists put a small protein called LL-37 onto specially textured titanium surfaces that are used for bone implants. In lab tests and in rats, this coating helped stem cells that can become bone cells move to the implant, stick to it, and turn into bone, leading to faster and stronger new bone growth around the implant.

Abstract

Titanium (Ti) and Ti-alloys were widely used in clinic orthopedics, however, the insufficient bone formation surrounding Ti-based implants still limited their biological performances. Surface modification of Ti substrates is essential to improve their interactions with bone-forming cells and bone tissue. In this study, we modified Ti substrates by coating peptide LL-37 onto micro-structured Ti substrates and aimed to (i) induce mesenchymal stem cells (MSCs) migration both in vitro and in vivo, (ii) facilitate osteogenic differentiation of MSCs and new bone formation. The surface micro-structured Ti substrates with hydroxyapatite deposition were fabricated by a two-step method including micro-arc oxidation (MAO) and hydrothermal treatment. LL-37 was loaded on micro-structured Ti substrates with the assistance of polydopamine coating. We confirmed that surface-modified Ti substrates benefited viability, adhesion, migration and osteogenic differentiation of MSCs in vitro. In a femur-defect rat model, the surface-modified Ti implants effectively induced CD29<sup>+</sup>/CD90<sup>+</sup> positive cells migration in one week after implantation. According to the results of H&amp;E, Masson's trichrome staining and immunohistochemical staining of OCN, OPN and collagen I, the targeted Ti implants exhibited significant new bone formation after implantation for 4&#x202f;weeks. These results indicate that the surface modification of Ti samples facilitated bone formation through MSCs recruitment. STATEMENT OF SIGNIFICANCE: The inherent surface bioinertness of titanium (Ti) and Ti-alloys still limits their biological performances in clinical applications. Recently, the strategy of mesenchymal stem cells (MSCs) recruitment has been proposed to improve the osteointegration of bone implants. Herein, we reports the surface modification of Ti implants from the point of MSCs recruitment. Peptide LL-37 was coated on micro-structured Ti substrates to (i) recruit MSCs, (ii) regulate bio-physiological performance of MSCs, and (iii) facilitate bone formation in vivo. Our results improve the understanding of the interaction between Ti implants and MSCs, and provide a promising strategy of MSCs recruitment in the design of bone repair related biomaterials.

Study Information

Provider

pubmed

Year

2018

Date

2018-09-25T00:00:00.000Z

DOI

10.1016/j.actbio.2018.09.036

Citations

74

References

48